PAA 2.78% 18.5¢ pharmaust limited

Management , Share Holder Communications, page-80

  1. 1,850 Posts.
    lightbulb Created with Sketch. 2251
    I just keep getting the sense that they would not be disappointed if the vet and human use deals all land the day Elanco rights go away for good. Now I really am getting cynical but if you look at the 2022 time lines for performance rights, it plays into that hypothesis
    Last edited by adreamer: Fix typo 17/09/20
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.